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Background: The Valve Academic Research Consortium (VARC)-2 has defined body mass index (BMI) <20 as indicative of frailty which 
may be one of the comorbidities not captured by traditional risk factors after transcatheter aortic valve implantation (TAVI). This study aimed 
to assess the impact of low BMI on clinical outcomes following TAVI.
methods: A total of 777 consecutive patients scheduled for TAVI were classified into 3 groups as BMI <20 (n=56), BMI 20-24.9 (n=322), 
and BMI ≥25 (n=399). Procedural complications and clinical outcomes were compared among the 3 groups. They were also analyzed 
according to propensity matching model A [BMI <20 (n=50) vs. BMI ≥20 (n=50)], model B [(BMI <20 (n=50) vs. BMI 20-24.9 (n=50)], and 
model C [BMI <20 (n=47) vs. BMI ≥25 (n=47)].
results: The differences in baseline characteristics between the 3 groups were adequately adjusted in 3 matched models. VARC-2 
defined endpoints and other complications were similar among the 3 groups in each model. Kaplan-Meier curves indicated no significant 
differences in cumulative 30-day survival [BMI <20 (91.0%) vs. BMI 20-24.9 (86.3%), p=0.33; BMI <20 (91.0%) vs. BMI ≥25 (91.4%), 
p=0.91; respectively] and 1-year survival [BMI <20 (74.3%) vs. BMI 20-24.9 (71.8%), p=0.71; BMI <20 (74.3%) vs. BMI ≥25 (77.0%), 
p=0.71; respectively]. These survival rates were also similar in each of the 3 matched models.
conclusion:  In this real world study, BMI <20 was not associated with increased early or mid-term mortality. BMI <20 alone may not 
constitute an additional comorbidity factor in TAVI patients.
